Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine in Elderly Patients with Advanced Colorectal Cancer
NCT00049335Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Feb 2003
- Primary completion
- Jun 2007
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine in colorectal cancer (CRC), sponsored by SWOG Cancer Research Network. Started Feb 2003; status: completed.
02
Drugs
capecitabine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00049335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00049335.